Annual EBITDA
$1.60 B
+$250.77 M+18.58%
30 June 2024
Summary:
ResMed annual earnings before interest, taxes, depreciation & amortization is currently $1.60 billion, with the most recent change of +$250.77 million (+18.58%) on 30 June 2024. During the last 3 years, it has risen by +$496.46 million (+44.97%). RMD annual EBITDA is now at all-time high.RMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$441.02 M
+$78.67 M+21.71%
30 September 2024
Summary:
ResMed quarterly earnings before interest, taxes, depreciation & amortization is currently $441.02 million, with the most recent change of +$78.67 million (+21.71%) on 30 September 2024. Over the past year, it has increased by +$98.58 million (+28.79%). RMD quarterly EBITDA is now at all-time high.RMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$1.63 B
+$98.58 M+6.46%
30 September 2024
Summary:
ResMed TTM earnings before interest, taxes, depreciation & amortization is currently $1.63 billion, with the most recent change of +$98.58 million (+6.46%) on 30 September 2024. Over the past year, it has increased by +$256.77 million (+18.76%). RMD TTM EBITDA is now at all-time high.RMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RMD EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.6% | +28.8% | +18.8% |
| 3 y3 years | +45.0% | +42.5% | +41.8% |
| 5 y5 years | +126.7% | +114.6% | +120.2% |
RMD EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +45.0% | at high | +55.9% | at high | +41.8% |
| 5 y | 5 years | at high | +126.7% | at high | +114.6% | at high | +120.2% |
| alltime | all time | at high | +4018.8% | at high | +601.1% | at high | +4080.0% |
ResMed EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $441.02 M(+21.7%) | $1.63 B(+6.5%) |
| June 2024 | $1.60 B(+18.6%) | $362.36 M(-15.6%) | $1.53 B(+1.6%) |
| Mar 2024 | - | $429.23 M(+9.3%) | $1.50 B(+5.3%) |
| Dec 2023 | - | $392.69 M(+14.7%) | $1.43 B(+4.3%) |
| Sept 2023 | - | $342.44 M(+1.2%) | $1.37 B(+1.7%) |
| June 2023 | $1.35 B(+12.8%) | $338.48 M(-4.2%) | $1.35 B(+4.3%) |
| Mar 2023 | - | $353.46 M(+5.8%) | $1.29 B(+5.5%) |
| Dec 2022 | - | $334.14 M(+4.5%) | $1.22 B(+3.0%) |
| Sept 2022 | - | $319.77 M(+13.0%) | $1.19 B(+0.9%) |
| June 2022 | $1.20 B(+8.3%) | $282.91 M(-1.0%) | $1.18 B(-0.4%) |
| Mar 2022 | - | $285.87 M(-4.2%) | $1.18 B(+1.2%) |
| Dec 2021 | - | $298.32 M(-3.6%) | $1.17 B(+1.7%) |
| Sept 2021 | - | $309.53 M(+7.7%) | $1.15 B(+3.9%) |
| June 2021 | $1.10 B(+11.5%) | $287.32 M(+5.9%) | $1.10 B(-1.3%) |
| Mar 2021 | - | $271.31 M(-2.6%) | $1.12 B(+2.1%) |
| Dec 2020 | - | $278.46 M(+4.4%) | $1.10 B(+4.2%) |
| Sept 2020 | - | $266.78 M(-11.8%) | $1.05 B(+6.2%) |
| June 2020 | $990.43 M(+40.3%) | $302.39 M(+21.9%) | $990.43 M(+18.1%) |
| Mar 2020 | - | $248.09 M(+5.8%) | $838.94 M(+7.2%) |
| Dec 2019 | - | $234.46 M(+14.1%) | $782.95 M(+6.0%) |
| Sept 2019 | - | $205.50 M(+36.2%) | $738.28 M(+4.6%) |
| June 2019 | $705.80 M(+3.8%) | $150.91 M(-21.4%) | $705.80 M(-5.1%) |
| Mar 2019 | - | $192.09 M(+1.2%) | $743.59 M(+3.5%) |
| Dec 2018 | - | $189.79 M(+9.7%) | $718.67 M(+1.6%) |
| Sept 2018 | - | $173.01 M(-8.3%) | $707.39 M(+4.0%) |
| June 2018 | $680.22 M(+19.6%) | $188.70 M(+12.9%) | $680.22 M(+3.5%) |
| Mar 2018 | - | $167.17 M(-6.4%) | $656.97 M(+3.7%) |
| Dec 2017 | - | $178.51 M(+22.4%) | $633.61 M(+8.2%) |
| Sept 2017 | - | $145.84 M(-11.9%) | $585.66 M(+3.3%) |
| June 2017 | $568.89 M(+5.8%) | $165.45 M(+15.0%) | $566.92 M(+0.9%) |
| Mar 2017 | - | $143.81 M(+10.1%) | $562.04 M(+3.6%) |
| Dec 2016 | - | $130.56 M(+2.7%) | $542.45 M(-1.1%) |
| Sept 2016 | - | $127.10 M(-20.8%) | $548.29 M(+2.0%) |
| June 2016 | $537.62 M(+4.4%) | $160.56 M(+29.3%) | $537.62 M(+2.1%) |
| Mar 2016 | - | $124.22 M(-8.9%) | $526.81 M(+0.1%) |
| Dec 2015 | - | $136.41 M(+17.2%) | $526.31 M(+1.6%) |
| Sept 2015 | - | $116.43 M(-22.3%) | $517.92 M(+0.6%) |
| June 2015 | $514.75 M(+0.8%) | $149.75 M(+21.0%) | $514.75 M(-0.1%) |
| Mar 2015 | - | $123.73 M(-3.3%) | $515.43 M(+0.4%) |
| Dec 2014 | - | $128.01 M(+13.0%) | $513.58 M(+0.9%) |
| Sept 2014 | - | $113.26 M(-24.7%) | $509.17 M(-0.3%) |
| June 2014 | $510.66 M(+8.7%) | $150.43 M(+23.4%) | $510.66 M(+1.6%) |
| Mar 2014 | - | $121.88 M(-1.4%) | $502.74 M(+1.0%) |
| Dec 2013 | - | $123.60 M(+7.7%) | $497.63 M(+2.5%) |
| Sept 2013 | - | $114.75 M(-19.5%) | $485.40 M(+3.3%) |
| June 2013 | $469.79 M(+11.2%) | $142.51 M(+22.0%) | $469.79 M(-2.5%) |
| Mar 2013 | - | $116.77 M(+4.9%) | $481.76 M(+4.4%) |
| Dec 2012 | - | $111.37 M(+12.3%) | $461.56 M(+4.8%) |
| Sept 2012 | - | $99.14 M(-35.8%) | $440.44 M(+4.2%) |
| June 2012 | $422.59 M(+12.4%) | $154.48 M(+60.0%) | $422.59 M(+7.8%) |
| Mar 2012 | - | $96.57 M(+7.0%) | $391.85 M(+3.8%) |
| Dec 2011 | - | $90.25 M(+11.0%) | $377.36 M(+0.8%) |
| Sept 2011 | - | $81.28 M(-34.3%) | $374.33 M(-0.5%) |
| June 2011 | $376.08 M(+15.8%) | $123.75 M(+50.8%) | $376.08 M(+5.6%) |
| Mar 2011 | - | $82.08 M(-5.9%) | $356.30 M(+1.1%) |
| Dec 2010 | - | $87.22 M(+5.0%) | $352.52 M(+3.7%) |
| Sept 2010 | - | $83.04 M(-20.1%) | $340.10 M(+4.7%) |
| June 2010 | $324.82 M(+33.0%) | $103.97 M(+32.8%) | $324.82 M(+11.0%) |
| Mar 2010 | - | $78.30 M(+4.7%) | $292.65 M(+4.6%) |
| Dec 2009 | - | $74.80 M(+10.4%) | $279.81 M(+7.2%) |
| Sept 2009 | - | $67.76 M(-5.6%) | $261.11 M(+6.9%) |
| June 2009 | $244.27 M | $71.80 M(+9.7%) | $244.27 M(+9.0%) |
| Mar 2009 | - | $65.45 M(+16.7%) | $224.01 M(+5.3%) |
| Dec 2008 | - | $56.10 M(+10.2%) | $212.75 M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2008 | - | $50.92 M(-1.2%) | $207.30 M(+1.2%) |
| June 2008 | $204.83 M(+48.1%) | $51.54 M(-4.9%) | $204.83 M(+1.2%) |
| Mar 2008 | - | $54.19 M(+7.0%) | $202.48 M(+46.0%) |
| Dec 2007 | - | $50.66 M(+4.6%) | $138.66 M(-1.5%) |
| Sept 2007 | - | $48.45 M(-1.5%) | $140.73 M(+1.8%) |
| June 2007 | $138.30 M(-20.5%) | $49.19 M(-610.5%) | $138.31 M(+0.2%) |
| Mar 2007 | - | -$9.63 M(-118.3%) | $137.98 M(-29.3%) |
| Dec 2006 | - | $52.73 M(+14.6%) | $195.18 M(+5.6%) |
| Sept 2006 | - | $46.02 M(-5.8%) | $184.76 M(+6.2%) |
| June 2006 | $174.04 M(+27.1%) | $48.86 M(+2.7%) | $174.04 M(+6.2%) |
| Mar 2006 | - | $47.56 M(+12.4%) | $163.84 M(+7.5%) |
| Dec 2005 | - | $42.31 M(+19.9%) | $152.37 M(+6.2%) |
| Sept 2005 | - | $35.31 M(-8.7%) | $143.45 M(+4.8%) |
| June 2005 | $136.90 M(+32.6%) | $38.66 M(+7.1%) | $136.90 M(+7.6%) |
| Mar 2005 | - | $36.09 M(+8.1%) | $127.26 M(+7.5%) |
| Dec 2004 | - | $33.40 M(+16.1%) | $118.41 M(+8.7%) |
| Sept 2004 | - | $28.75 M(-0.9%) | $108.91 M(+5.5%) |
| June 2004 | $103.23 M(+29.3%) | $29.02 M(+6.5%) | $103.23 M(+7.8%) |
| Mar 2004 | - | $27.24 M(+14.0%) | $95.75 M(+7.6%) |
| Dec 2003 | - | $23.90 M(+3.6%) | $89.01 M(+5.4%) |
| Sept 2003 | - | $23.08 M(+7.1%) | $84.42 M(+5.8%) |
| June 2003 | $79.82 M(-295.5%) | $21.54 M(+5.1%) | $79.82 M(-368.6%) |
| Mar 2003 | - | $20.49 M(+6.2%) | -$29.72 M(-14.5%) |
| Dec 2002 | - | $19.30 M(+4.4%) | -$34.77 M(-8.7%) |
| Sept 2002 | - | $18.48 M(-121.0%) | -$38.07 M(-6.8%) |
| June 2002 | -$40.84 M(-178.3%) | -$88.00 M(-669.9%) | -$40.84 M(-171.9%) |
| Mar 2002 | - | $15.44 M(-3.5%) | $56.84 M(-1.2%) |
| Dec 2001 | - | $16.00 M(+1.8%) | $57.50 M(+8.4%) |
| Sept 2001 | - | $15.72 M(+62.5%) | $53.07 M(+9.6%) |
| June 2001 | $52.16 M(+32.4%) | $9.67 M(-40.0%) | $48.42 M(-1.3%) |
| Mar 2001 | - | $16.11 M(+39.2%) | $49.03 M(+13.7%) |
| Dec 2000 | - | $11.57 M(+4.5%) | $43.14 M(+3.8%) |
| Sept 2000 | - | $11.07 M(+7.7%) | $41.57 M(+5.7%) |
| June 2000 | $39.39 M(+31.7%) | $10.28 M(+0.6%) | $39.34 M(+4.7%) |
| Mar 2000 | - | $10.22 M(+2.2%) | $37.56 M(+6.3%) |
| Dec 1999 | - | $10.00 M(+13.1%) | $35.34 M(+8.9%) |
| Sept 1999 | - | $8.85 M(+4.1%) | $32.45 M(+8.5%) |
| June 1999 | $29.90 M(+42.4%) | $8.50 M(+6.3%) | $29.90 M(+7.2%) |
| Mar 1999 | - | $8.00 M(+12.7%) | $27.90 M(+9.4%) |
| Dec 1998 | - | $7.10 M(+12.7%) | $25.50 M(+7.1%) |
| Sept 1998 | - | $6.30 M(-3.1%) | $23.80 M(+13.3%) |
| June 1998 | $21.00 M(+92.7%) | $6.50 M(+16.1%) | $21.00 M(+17.3%) |
| Mar 1998 | - | $5.60 M(+3.7%) | $17.90 M(+17.8%) |
| Dec 1997 | - | $5.40 M(+54.3%) | $15.20 M(+23.6%) |
| Sept 1997 | - | $3.50 M(+2.9%) | $12.30 M(+13.9%) |
| June 1997 | $10.90 M(+122.4%) | $3.40 M(+17.2%) | $10.80 M(+18.7%) |
| Mar 1997 | - | $2.90 M(+16.0%) | $9.10 M(+21.3%) |
| Dec 1996 | - | $2.50 M(+25.0%) | $7.50 M(-41.9%) |
| Sept 1996 | - | $2.00 M(+17.6%) | $12.90 M(-26.7%) |
| June 1996 | $4.90 M(+44.1%) | $1.70 M(+30.8%) | $17.60 M(+826.3%) |
| Mar 1996 | - | $1.30 M(-83.5%) | $1.90 M(-69.4%) |
| Dec 1995 | - | $7.90 M(+17.9%) | $6.20 M(+59.0%) |
| Sept 1995 | - | $6.70 M(-147.9%) | $3.90 M(+39.3%) |
| June 1995 | $3.40 M(+112.5%) | -$14.00 M(-350.0%) | $2.80 M(-63.2%) |
| Mar 1995 | - | $5.60 M(0.0%) | $7.60 M(+38.2%) |
| Dec 1994 | - | $5.60 M(0.0%) | $5.50 M(+61.8%) |
| Sept 1994 | - | $5.60 M(-160.9%) | $3.40 M(+161.5%) |
| June 1994 | $1.60 M(+77.8%) | -$9.20 M(-362.9%) | $1.30 M(-76.4%) |
| Mar 1994 | - | $3.50 M(0.0%) | $5.50 M(+41.0%) |
| Dec 1993 | - | $3.50 M(0.0%) | $3.90 M(+69.6%) |
| Sept 1993 | - | $3.50 M(-170.0%) | $2.30 M(+228.6%) |
| June 1993 | $900.00 K | -$5.00 M(-363.2%) | $700.00 K(-87.7%) |
| Mar 1993 | - | $1.90 M(0.0%) | $5.70 M(+50.0%) |
| Dec 1992 | - | $1.90 M(0.0%) | $3.80 M(+100.0%) |
| Sept 1992 | - | $1.90 M | $1.90 M |
FAQ
- What is ResMed annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for ResMed?
- What is ResMed annual EBITDA year-on-year change?
- What is ResMed quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for ResMed?
- What is ResMed quarterly EBITDA year-on-year change?
- What is ResMed TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for ResMed?
- What is ResMed TTM EBITDA year-on-year change?
What is ResMed annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of RMD is $1.60 B
What is the all time high annual EBITDA for ResMed?
ResMed all-time high annual earnings before interest, taxes, depreciation & amortization is $1.60 B
What is ResMed annual EBITDA year-on-year change?
Over the past year, RMD annual earnings before interest, taxes, depreciation & amortization has changed by +$250.77 M (+18.58%)
What is ResMed quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of RMD is $441.02 M
What is the all time high quarterly EBITDA for ResMed?
ResMed all-time high quarterly earnings before interest, taxes, depreciation & amortization is $441.02 M
What is ResMed quarterly EBITDA year-on-year change?
Over the past year, RMD quarterly earnings before interest, taxes, depreciation & amortization has changed by +$98.58 M (+28.79%)
What is ResMed TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of RMD is $1.63 B
What is the all time high TTM EBITDA for ResMed?
ResMed all-time high TTM earnings before interest, taxes, depreciation & amortization is $1.63 B
What is ResMed TTM EBITDA year-on-year change?
Over the past year, RMD TTM earnings before interest, taxes, depreciation & amortization has changed by +$256.77 M (+18.76%)